Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Clinical Investigation

• Publication date

  2009-11-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI39199PMID 19805909PMCID PMC2769176
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Challenge of Finding a Cure for HIV Infection

  2009cited by this paper
• Induction of HIV-1 latency and reactivation in primary memory CD4+ T cells.

  2009cited by this paper
• HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

  2009cited by this paper
• Human Immunodeficiency Virus Integration Efficiency and Site Selection in Quiescent CD4+ T Cells

  2009cited by this paper
• Human Immunodeficiency Virus Integrates Directly into Naïve Resting CD4+ T Cells but Enters Naïve Cells Less Efficiently than Memory Cells

  2009cited by this paper
• Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cells.

  2008cited by this paper
• Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis*

  2008cited by this paper
• An In Vitro System to Model the Establishment and Reactivation of HIV-1 Latency

  2008cited by this paper
• Hide-and-seek: the challenge of viral persistence in HIV-1 infection.

  2008cited by this paper
• Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

  2008cited by this paper
• Microbicide Fails to Protect Against HIV

  2008cited by this paper
• Primary Cell Model for Activation-Inducible Human Immunodeficiency Virus

  2007cited by this paper
• HMBA Releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and Activates HIV Transcription

  2007cited by this paper
• HIV vaccine may raise risk

  2007cited by this paper
• Interlinking interleukin-7.

  2007cited by this paper
• A clinical drug library screen identifies astemizole as an antimalarial agent

  2006cited by this paper
• NF-kappaB activation by reactive oxygen species: fifteen years later.

  2006cited by this paper
• A novel in vitro system to generate and study latently HIV-infected long-lived normal CD4+ T-lymphocytes.

  2006cited by this paper
• NF-κB activation by reactive oxygen species: Fifteen years later

  2006cited by this paper
• The Vif and Vpr accessory proteins independently cause HIV-1-induced T cell cytopathicity and cell cycle arrest.

  2006cited by this paper
• Depletion of Latent HIV-1 Infection In Vivo: A Proof-of-Concept Study

  2006cited by this paper
• Attacking HIV provirus: therapeutic strategies to disrupt persistent infection.

  2006cited by this paper
• IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

  2005cited by this paper
• Human Immunodeficiency Virus Type 1 Can Establish Latent Infection in Resting CD4+ T Cells in the Absence of Activating Stimuli

  2005cited by this paper
• NFAT proteins: key regulators of T-cell development and function

  2005cited by this paper
• Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.

  2005cited by this paper
• Analysis of Human Immunodeficiency Virus Type 1 Transcriptional Elongation in Resting CD4+ T Cells In Vivo

  2004cited by this paper
• Central memory and effector memory T cell subsets: function, generation, and maintenance.

  2004cited by this paper
• The multifactorial nature of HIV-1 latency.

  2004cited by this paper
• Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1

  2004cited by this paper
• Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells

  2003cited by this paper
• Control of T cell viability.

  2003cited by this paper
• Molecular characterization, reactivation, and depletion of latent HIV.

  2003cited by this paper
• IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells

  2003cited by this paper
• Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells

  2003cited by this paper
• HIV reproducibly establishes a latent infection after acute infection of T cells in vitro

  2003cited by this paper
• Identification of T cell-signaling pathways that stimulate latent HIV in primary cells

  2003cited by this paper
• Death and Baxes: mechanisms of lymphotrophic cytokines

  2003cited by this paper
• Protein kinase C(theta) in T cell activation.

  2002cited by this paper
• Interleukin-7 Induces Expression of Latent Human Immunodeficiency Virus Type 1 with Minimal Effects on T-Cell Phenotype

  2002cited by this paper
• The challenge of viral reservoirs in HIV-1 infection.

  2002cited by this paper
• Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

  2002cited by this paper
• Generation of HIV latency during thymopoiesis

  2001cited by this paper
• OKT3 and IL-2 Treatment for Purging of the Latent HIV-1 Reservoir in Vivo Results in Selective Long-Lasting CD4+ T Cell Depletion

  2001cited by this paper
• Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART.

  2001cited by this paper
• IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1

  2001cited by this paper
• Characterization of Chemokine Receptor Utilization of Viruses in the Latent Reservoir for Human Immunodeficiency Virus Type 1

  2000cited by this paper
• NF-kappa B and HIV: linking viral and immune activation.

  2000cited by this paper
• Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.

  2000cited by this paper
• NF-κB and HIV: Linking viral and immune activation

  2000cited by this paper
• Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy

  1999cited by this paper
• Nonproductive Human Immunodeficiency Virus Type 1 Infection in Nucleoside-Treated G0 Lymphocytes

  1999cited by this paper
• Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.

  1999cited by this paper
• The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens.

  1998cited by this paper
• High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells

  1998cited by this paper
• Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines

  1998cited by this paper
• Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone.

  1998cited by this paper
• The kappaB sites in the human immunodeficiency virus type 1 long terminal repeat enhance virus replication yet are not absolutely required for viral growth

  1997cited by this paper
• The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells.

  1997cited by this paper
• Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.

  1997cited by this paper
• Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

  1997cited by this paper
• Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.

  1997cited by this paper
• HIV-induced T cell syncytia are self-perpetuating and the primary cause of T cell death in culture.

  1997cited by this paper
• Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/- mice.

  1997cited by this paper
• Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

  1997cited by this paper
• Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

  1997cited by this paper
• A human peptidyl–prolyl isomerase essential for regulation of mitosis

  1996cited by this paper
• In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency

  1995cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• An inducible transcription factor activates expression of human immunodeficiency virus in T cells

  1990cited by this paper
• A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123.

  1990cited by this paper
• Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

  1989cited by this paper
• Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.

  1989cited by this paper
• The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

  1988cited by this paper
• Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

  1987cited by this paper
• An inducible transcription factor activates expression of human immunodeficiency virus in T cells

  1987cited by this paper
• Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.

  1987cited by this paper
• Superoxide, hydrogen peroxide, and oxygen toxicity in two free-living nematode species.

  1983cited by this paper
• Flow cytometric estimation of DNA and RNA content in intact cells stained with Hoechst 33342 and pyronin Y.

  1981cited by this paper
• Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds.

  1979cited by this paper

• Superinfection with intact HIV-1 results in conditional replication of defective proviruses and nonsuppressible viremia in people living with HIV-1

  2025cites this paper
• A targeted CRISPR screen identifies ETS1 as a regulator of HIV-1 latency

  2025cites this paper
• HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cells

  2025cites this paper
• HIV-1 transcription dominates over host gene activity at the HIV-1 integration site

  2025influential citation
• Using single cell technologies to understand HIV latency models.

  2025cites this paper
• Modeling simian immunodeficiency virus (SIV) latency in primary rhesus macaque CD4+ T cells

  2025cites this paper
• Heat shock protein 90 is a chaperone regulator of HIV-1 latency

  2025influential citation
• Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse model

  2025cites this paper
• Superinfection promotes replication and diversification of defective HIV-1 proviruses in people with non-suppressible viraemia

  2025cites this paper
• Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR

  2024cites this paper
• PADI4-mediated citrullination of histone H3 stimulates HIV-1 transcription

  2024cites this paper
• HIV Reservoirs and Treatment Strategies toward Curing HIV Infection

  2024cites this paper
• Emerging roles of senolytics/senomorphics in HIV-related co-morbidities.

  2024cites this paper
• Sex and Age Impact CD4+ T Cell Susceptibility to HIV In Vitro through Cell Activation Dynamics

  2023cites this paper
• Humanized Mice for Studies of HIV-1 Persistence and Elimination

  2023cites this paper
• Integration site–dependent HIV-1 promoter activity shapes host chromatin conformation

  2023cites this paper
• A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV-infected cells.

  2023cites this paper
• Gold nanocubes based optical detection of HIV-1 DNA via surface enhanced Raman spectroscopy.

  2023cites this paper
• HIV-Tocky system to visualize proviral expression dynamics

  2023cites this paper
• A novel high-throughput microwell outgrowth assay for HIV-infected cells

  2023cites this paper
• Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation

  2022cites this paper
• So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research

  2022cites this paper
• Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen

  2022cites this paper
• The Cultured TCM Model of HIV Latency.

  2022cites this paper
• Lentiviral Nef Proteins Differentially Govern the Establishment of Viral Latency

  2022cites this paper
• Bimodal Expression Patterns, and Not Viral Burst Sizes, Predict the Effects of Vpr on HIV-1 Proviral Populations in Jurkat Cells

  2022cites this paper
• A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV infected cells

  2022cites this paper
• Integrated Single-cell Multiomic Analysis of HIV Latency Reversal Reveals Novel Regulators of Viral Reactivation

  2022cites this paper
• A modular CRISPR screen identifies individual and combination pathways contributing to HIV-1 latency

  2022cites this paper
• Prime, shock and kill: BCL-2 inhibition for HIV cure

  2022cites this paper
• Inception of redox cycling and its impact in biology and medicine.

  2022cites this paper
• FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promotes AKT activation and tumorigenesis in ovarian cancer cells

  2022cites this paper
• Host–virus interaction and viral evasion

  2021cites this paper
• Infection with a newly designed dual fluorescent reporter HIV-1 effectively identifies latently infected CD4+ T cells

  2021cites this paper
• Shock-and-kill versus block-and-lock: Targeting the fluctuating and heterogeneous HIV-1 gene expression

  2021cites this paper
• Evaluation of HIV-1 Latency Reversal and Antibody-Dependent Viral Clearance by Quantification of Singly Spliced HIV-1 vpu/env mRNA

  2021cites this paper
• Vpr shapes the proviral landscape and polyclonal HIV-1 reactivation patterns in cultured cells

  2021cites this paper
• A widely distributed HIV-1 provirus elimination assay to evaluate latency-reversing agents in vitro

  2021influential citation
• Discovery of juglone and its derivatives as potent SARS-CoV-2 main proteinase inhibitors

  2021cites this paper
• A multidimensional HIV-1 persistence model for clonal expansion and viral rebound in vitro

  2021cites this paper
• Activation of the Anti-Oxidative Stress Response Reactivates Latent HIV-1 Through the Mitochondrial Antiviral Signaling Protein Isoform MiniMAVS

  2021influential citation
• Identification and characterization of Stathmin 1 as a host factor involved in HIV-1 latency.

  2021cites this paper
• Antioxidant nanozyme counteracts HIV‐1 by modulating intracellular redox potential

  2021cites this paper
• HIV-1 PERSISTENCE IN THE CNS: MECHANISMS OF LATENCY, PATHOGENESIS AND AN UPDATE ON ERADICATION STRATEGIES.

  2021cites this paper
• The role of oxidative stress in HIV-associated neurocognitive disorders

  2021cites this paper
• Future approaches to clearing the latent human immunodeficiency virus reservoir: Beyond latency reversal

  2020cites this paper
• Maraviroc reactivates HIV with potency similar to that of other latency reversing drugs without inducing toxicity in CD8 T cells.

  2020cites this paper
• Identification of unrecognized host factors promoting HIV-1 latency

  2020influential citation
• Experimental Systems for Measuring HIV Latency and Reactivation

  2020cites this paper
• Human splice factors contribute to latent HIV infection in primary cell models and blood CD4+ T cells from ART-treated individuals

  2020cites this paper
• Human Immunodeficiency Virus 1 (HIV-1): Viral Latency, the Reservoir, and the Cure

  2020cites this paper
• NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling

  2020cites this paper
• Epigenomic characterization of latent HIV infection identifies latency regulating transcription factors

  2020cites this paper
• Single-cell transcriptional landscapes reveal HIV-1–driven aberrant host gene transcription as a potential therapeutic target

  2020cites this paper
• Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation.

  2020influential citation
• Identification of novel cellular factors involved in HIV-1 latency

  2020cites this paper
• Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response

  2020cites this paper
• The African natural product knipholone anthrone and its analogue anthralin (dithranol) enhance HIV-1 latency reversal

  2020cites this paper
• CRNKL1 Is a Highly Selective Regulator of Intron-Retaining HIV-1 and Cellular mRNAs

  2020cites this paper
• HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs In Vitro and Ex Vivo

  2020cites this paper
• HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal

  2019cites this paper
• Small molecules effective for disruption of HIV-1 latency

  2019cites this paper
• Heterogeneity in HIV and cellular transcription profiles in cell line models of latent and productive infection: implications for HIV latency

  2019cites this paper
• Zezhou Zhao_Masters Thesis

  2019cites this paper
• The WIPE assay for selection and elimination of HIV-1 provirus in vitro using latency-reversing agents

  2019cites this paper
• Diversity of small molecule HIV‐1 latency reversing agents identified in low‐ and high‐throughput small molecule screens

  2019cites this paper
• Activation of Latent HIV-1 T Cell Reservoirs with a Combination of Innate Immune and Epigenetic Regulators

  2019cites this paper
• Nitric oxide stimulates a PKC-Src-Akt signaling axis which increases human immunodeficiency virus type 1 replication in human T lymphocytes.

  2019cites this paper
• The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence

  2019cites this paper
• A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b.

  2019cites this paper
• Unveiling the druggable RNA targets and small molecule therapeutics

  2019cites this paper
• Perspective on potential impact of HIV CNS latency on eradication.

  2019cites this paper
• The role of catecholamines in HIV neuropathogenesis.

  2019cites this paper
• Chromatin maturation of the HIV-1 provirus in primary resting CD4+ T cells

  2019cites this paper
• Characterizing the Latent HIV-1 Reservoir in Patients with Viremia Suppressed on cART: Progress, Challenges, and Opportunities

  2019cites this paper
• STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques

  2019cites this paper
• Modeling HIV-1 Latency Using Primary CD4+ T Cells from Virally Suppressed HIV-1-Infected Individuals on Antiretroviral Therapy

  2019cites this paper
• HIV "shock and kill" therapy: In need of revision.

  2019cites this paper
• Selective miRNA Modulation Fails to Activate HIV Replication in In Vitro Latency Models

  2019cites this paper
• The role of latency reversal agents in the cure of HIV: A review of current data.

  2018cites this paper
• Therapeutic manipulation of host cell death pathways to facilitate clearance of persistent viral infections

  2018cites this paper
• Single cell analysis of quiescent HIV infection reveals host transcriptional profiles that regulate proviral latency

  2018cites this paper
• Peering into the HIV reservoir

  2018cites this paper
• Barriers for HIV Cure: The Latent Reservoir

  2018cites this paper
• Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro

  2018cites this paper
• Investigating the role of HIV-1 Nef during reactivation of latent viral reservoirs

  2018cites this paper
• CD4+ T Cell Subsets and Pathways to HIV Latency

  2018cites this paper
• Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus

  2018cites this paper
• Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products

  2018cites this paper
• Targeting the Latent Reservoir for HIV‐1

  2018cites this paper
• КЛЕТОЧНЫЕ ТЕХНОЛОГИИ В ФАРМАКОЛОГИЧЕСКИХ ИССЛЕДОВАНИЯХ. НАСТОЯЩЕЕ И БУДУЩЕЕ, "Цитология"

  2018cites this paper
• Clinical Interventions in HIV Cure Research.

  2018cites this paper
• Role of Innate Genes in HIV Replication.

  2018cites this paper
• Oncolytic Viruses as a Potential Approach to Eliminate Cells That Constitute the Latent HIV Reservoir

  2018cites this paper
• In Vitro and In Vivo Models of HIV Latency.

  2018cites this paper
• Higher expression of human telomerase reverse transcriptase in productively‐infected CD4 cells possibly indicates a mechanism for persistence of the virus in HIV infection

  2018cites this paper
• Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

  2017cites this paper
• The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure

  2017cites this paper
• Resveratrol Reactivates Latent HIV through Increasing Histone Acetylation and Activating Heat Shock Factor 1.

  2017cites this paper
• Dendritic cells maturated by co-culturing with HIV-1 latently infected Jurkat T cells or stimulating with AIDS-associated pathogens secrete TNF-α to reactivate HIV-1 from latency

  2017cites this paper